Introduction
Complex partial seizures generalize through well defined anatomic pathways. The dorsomedian nucleus of the thalamus (DMNT) is well connected to the amygdala and other limbic structures and may have an important role in the propagation of these seizures. 1, 2 Lesions in DMNT disrupt the propagation of some experimental seizures in rats. 3 In the same way, drug infusion in the DMNT could modulate the intensity of limbic seizures. Seizure duration can be reduced by acute infusion of the GABA agonist muscimol, and can be prolonged by the acute infusion of the GABA antagonist bicuculline. 4 Likewise, bilateral injection in DMNT of glutamate antagonists or GABA agonists inhibits seizures provoked by systemic pilocarpine. 5 Also, ipsilateral DMNT injection of similar drugs inhibits generalization of limbic seizures acutely induced by infusion of bicuculline at the ''area tempestas''. 2 However, clinical applicability requires a more prolonged effect, which could be provided by chronic administration of the drugs. We have shown that continuous infusion of GABA via osmotic minipumps at the amygdala may increase the threshold to provoke local afterdischarges and clinical seizures in amygdala-kindled rats. 6 The use of this chronic model of limbic seizures may be useful to replicate human partial complex seizures with secondary generalization, 7, 8 and therefore to explore the role of chronic intracerebral drug infusion in the clinical setting. Another advantage of the amygdala-kindling model is that once animals are fully kindled, further stimulations do not change the variables that define the model, 8 so it is possible to repeat the experiments daily for an extended period. This suits to the clinical practice, since patients use to be treated after having developed epilepsy, not preventively. The aim of this study is to test the effect on seizures and neurologic side effects of bilateral continuous GABA infusion within the DMNT in amygdala-kindled rats.
Materials and methods
We used adult male Wistar rats, bred in the facilities of the Research Centre of the University General Hospital in Valencia (Spain). The experimental protocol was approved by the corresponding institutional animal care committee, in compliance with g-Aminobutyric acid
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In order to assess the role of continuous intracerebral infusion of GABA over the propagation of generalized seizures from the amygdala, Wistar rats were subjected to a kindling procedure at the left basolateral amygdala. Subsequently, they were implanted with miniosmotic pumps filled with 100 mg/ mL of GABA in saline, connected to catheters whose tips were placed bilaterally at both dorsomedian nuclei of the thalamus (DMNT). The threshold intensity to provoke local afterdischarges (ADT) and generalized seizures (GST) were measured before, during and after GABA infusion, as well as seizure intensity and signs of ataxia and sedation.
While there was no observed variation on ADT, the median GST was significantly increased during, but not after infusion of GABA (P = 0.047, compared to the preinfusion value). Seizure intensity was not changed. No signs of neurologic side effects were recorded. These data emphasize the role of DMNT in the generalization of seizures originated at the amygdala.
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Seizure j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / y s e i z current European directives for animal experimentation (86/609/ ECC) and with those set by the Valencian Community Government. Under general anesthesia afforded with an intraperitoneal injection of a mixture of ketamine (100 mg/kg), diazepam (8 mg/ kg) and atropine sulphate (0.4 mg/kg), animals weighting 270-310 g were stereotactically implanted with a bipolar electrode at the left basolateral amygdala. The electrode consisted of a twisted pair of 0.2 mm diameter Teflon-coated stainless steel wires (Advent Research Materials, Suffolk, England), the tips of which were exposed by 0.2 mm and separated by 0.5 mm, and then placed at the following coordinates: 2.2 mm posterior, 4.8 mm left, and 8.5 mm ventral from the bregma. 9 Also, two cannulae made of stainless steel (0.7 mm outer diameter) were stereotactically implanted bilaterally at coordinates corresponding to the DMNT: 2.8 mm posterior, 0.7 mm lateral and 5.4 mm ventral), with a lateral inclination of 158 in order to avoid the superior longitudinal sinus. Four symmetrical, chlorinated, silver recording electrodes were implanted into the epidural space (two frontal and two occipital). In addition, an indifferent electrode was placed under the skin of the neck. All electrodes were connected to a 7-pin miniature connector. The cannula, electrodes and connector were fixed to the skull vault with dental acrylic cement, and the skin was closed with silk suture at both ends of the incision. After surgery, animals were individually caged.
A standard kindling procedure commenced 10 days after surgery, which involved daily stimulation with a 1-s train of 50 Hz square wave pulses (1 ms duration and 500 mA amplitude), using a Grass S88 stimulator, until more than three consecutive stage 5 seizures 10 were provoked. At this point, the animal was considered fully kindled, and the afterdischarge threshold (ADT) and seizure threshold (ST) were determined. This was done by using a stepwise ascent method, 11 consisting of stimulation with a series of 1-s train of 50 Hz square wave, in pulses lasting 1 ms, separated by 1 min intervals. Current intensity began at an amplitude of 7 mA and was increased gradually, by 20% each step, to 500 mA, or until a behavioral seizure occurred. The amplitude reached when a seizure was produced was considered to be the ST. Similarly, the lowest amplitude to elicit an afterdischarge recorded from the amygdalar electrode of at least 5 s was considered to be the ADT. This procedure was repeated over the following 2 days, and the median of the three determinations was considered as the control threshold value. After basal seizure readings were taken, animals were assigned to one of two groups: those receiving bilateral GABA infusion (n = 7), or bilateral sham infusion of hyperosmotic saline (n = 2). They were anesthetised once more with the same intraperitoneal injection mixture as previously described, and two miniosmotic pumps (Alzet model 2001, with outer dimensions 3.0 cm Â 0.7 cm, 200 mL reservoir volume and infusion rate of 0.5 mL/h, Alza Corp., California) were subcutaneously implanted in the upper dorsal region. Pumps were filled either with a 100 mg/mL GABA solution in saline, or a saline concentration with osmotic pressure matching that of 100 mg/mL GABA, and were connected to a silicone tube (50 mm long, 0.5 mm inner diameter), which was filled with the same solution after the pump had been incubated in a saline bath for 1 h at 37.5 8C. The tubes were connected to both DMNT catheters accordingly.
The anticonvulsant efficacy and the neurologic side effects were determined at the same time each day over two 5 consecutive day period the next 2 weeks, starting 48 h after pump implantation. As the pump works for only 7 days, the first week was considered as the infusion period and the second week the postinfusion period. Measures of these experiments were performed by investigators who were blinded to the actual treatment of the animal. The anticonvulsant effect determination was performed by stimulation of the left amygdala. The ADT and the ST were measured using the stepwise ascent method described in the previous section; when a generalized seizure was produced, the ST was considered as the generalized seizure threshold (GST). Afterdischarge duration (ADD), i.e., the time elapsed between the onset of epileptiform electric activity and its disappearance, and seizure duration (SD), i.e., the time between the onset of seizure-like behavior and its disappearance, were also recorded. Also, seizure severity (SS), measured on the Racine scale, 10 was determined. Neurological side effects were tested immediately prior to stimulation by means of an observational neurological examination, and then scoring ataxia and sedation according to the following scales 12 ; ataxia: 0 = absent; 1 = slight ataxia in hindlegs; 2 = more pronounced ataxia with dragging of hindlegs; 3 = further increase of ataxia and more pronounced dragging of hindlegs; 4 = marked ataxia and loss of balance during forward locomotion; 5 = considerably marked ataxia with frequent loss of balance; 6 = permanent loss of righting reflex; sedation: 0 = absent; 1 = slightly reduced forward locomotion; 2 = reduced locomotion with rest periods between periods of locomotion; 3 = reduced locomotion with more frequent rest periods; 4 = no forward locomotion and the animal sits still with closed eyes.
Once the experiments were completed, animals were sacrificed with an intraperitoneal injection of pentobarbital, and the pumps explanted and inspected to confirm adequate voiding. Gross inspection showed a proper position of the electrode tip and catheters, although this was not histochemically confirmed.
Wilcoxon's signed rank test for paired replicates 13 was used to calculate the significance of individual differences between seizure parameters during and after GABA infusion against controls of the same animals before GABA infusion. Statistical significance was considered when P < 0.05.
Results
Results are summarized in Table 1 . In the GABA infusion group, no significant changes were observed in ADT, which was stable through the whole experiment (Fig. 1) . On the other hand, SS showed a wide variability in the GABA infusion group. Therefore some animals infused with GABA showed a complete suppression of seizures, but some others had no changes. As a matter of fact this result was not statistically significant.
Results on GST also marked a great variability among different animals and among different days of the week. A significant elevation (P = 0.047) of the median GST, was shown during the week of infusion (but not in a day by day basis) in the GABA infusion group as compared to the preinfusion value (Fig. 1) . In the postinfusion period, the GST showed a trend towards basal values, showing no significant difference with preinfusion values.
On the contrary, no significative change was observed in any of the kindling parameters in the animals receiving bilateral infusion of control solution.
No neurologic side effect was observed in any of the groups.
Discussion
Focal treatment for epileptic patients in the place where seizures originate is not always possible, since sometimes the location of this place cannot be established, or it can be extensive or multiple, or its inhibition can lead to adverse effects worse than the epileptic condition. In such cases, instead of the epileptogenic area, it may be better to inhibit the pathways which propagate epileptic activity to the rest of the brain.
Some approaches involving the increase activity of inhibitory centers have been considered, such as stimulation of the cerebellum, 14 the striatum 15 or the subthalamic nucleus. 16 Also, the thalamus has been used as a target to block seizure propagation. For example, centromedian thalamic inhibitory electric currents may control absence seizures in patients. 17 Also, stimulation of the anterior nucleus of the thalamus may influence the generalization of seizures. 18 Similar effects may be obtained by injection of GABA agonists in other thalamic nuclei. 19 Focal seizures of limbic origin propagate through anatomically well defined pathways. 1 The main thalamic projection of the amygdala is to the DMNT, especially its medial part. This projects to the orbitofrontal cortex and is more important in man than in other mammals. It makes the DMNT a suitable target to block propagation of seizures originating from the amygdala. Lesion or Table 1 Effect on the seizure parameters recorded before (preinfusion), during (days 3-7) and after (days 10-14) continuous bilateral infusion of GABA in the dorsomedian nucleus of the thalamus. Each parameter is expressed as median (minimum, maximum). ADT, afterdischarge threshold (mA); ADD, afterdischarge duration (s); GST, generalized seizure threshold (mA); GSD, generalized seizure duration (s); SS, seizure severity (Racine's score). acute injection of glutamate antagonists or GABA agonists at the DMNT inhibits generalization of experimental seizures. [2] [3] [4] [5] Our data show that GABA infusion in the DMNT gets a mild but significant inhibition of the generalization of epileptic seizures during the infusion period. There is no effect on the focal seizure activity, which suggests that GABA does not reach the amygdala, where seizures originate, in a sufficient amount. We showed in an earlier experiment that local infusion of GABA in the amygdala elevates the ADT. 6 In order to transfer these results to the clinic, it is necessary to maintain the inhibitory effect in a chronic basis. Continuous local infusion of GABA may inhibit local brain function, as Will et al. 20 showed by locally infusing GABA into the nucleus basalis of the rat. The basis for intracerebral GABA infusion as a treatment for epilepsy is the restoration of the imbalance between glutamatergic and GABAergic synaptic transmission. 21 This approach has been used to block the behavioral manisfestations of seizures in a model of limbic seizures by cortically infusing GABA. 22 This was followed by spontaneous afterdischarge generation when GABA infusion was stopped. In our experiment, the anticonvulsant effect is not maintained during the postinfusion week, which supports the causative effect of GABA during the infusion and the reversibility of the effect.
Previous to infusion
On the other hand, this effect of the GABA infusion consists of higher GST, but there are not significant changes in seizure severity scored according to Racine. 10 This means that, once propagated, seizures develop fully in spite of the thalamic block. This could be explained by increased connectivity between amygdala and frontal cortex as a result of kindling. 23 Surgical alternatives to antiepileptic drugs are considered when drug resistant seizures develop. Although the strategy considered here does not rely in augmenting the bioavailability of the drug at the epileptic area, but rather in blocking the spread of the seizures, it would be interesting to study the differential effect of this treatment on drug resistant rats. The kindling model of epilepsy permits the selection of animals resistant to specific drugs (e.g., phenytoin), 7 as thus it would be possible to determine if GABA infusion within the NDMT is valid in phenytoin resistant animals. Technically, focal delivery of GABA by means of external pumps may jeopardize its clinical use, since issues of recharging the contents of the pump may be raised. A more stable means to locally deliver GABA could be the implantation of genetically modified GABA producing cells, as other authors have used at the pyriform cortex 24 or the dentate gyrus. 25 Also, NDMT could be an alternative target for deep brain stimulation in drug resistant temporolimbic epilepsy. 18 In conclusion, this study shows that continuous bilateral infusion of GABA in the dorsomedian nucleus of the thalamus elevates the generalized seizure threshold in amygdala-kindled rats, without affecting afterdischarge threshold. This shows the possibility to inhibit the generalization of seizures without acting on the epileptogenic area. New techniques should be developed to deliver GABA in the pathways of propagation of seizures as a treatment of epilepsy.
